Shareholding4 Jul 2026, 11:30 am

Gujarat Themis Biosyn: Promoter Group Indirectly Encumbers 47.02% Stake

AI Summary

Gujarat Themis Biosyn Limited (GTBL) has disclosed an indirect encumbrance on a significant portion of its share capital. Pharmaceutical Business Group (India) Limited (PBGIL), a promoter group entity holding 47.02% of GTBL's equity, has had its shares encumbered. This encumbrance arises from a pledge over 51% of PBGIL's shares and a non-disposal undertaking over 47.98% of PBGIL's shares, executed by Vividhmargi Investments Private Limited (VIPL) in favor of CTL Trusteeship Limited. The encumbrance is linked to a Debenture Trust Deed and a Pledge Agreement-cum-Non-Disposal Undertaking dated June 2026.

Key Highlights

Indirect encumbrance on 47.02% of Gujarat Themis Biosyn shares.
Encumbrance stems from actions on promoter group entity PBGIL.
Pledge and non-disposal undertaking involve over 51% and 47.98% of PBGIL.
CTL Trusteeship Limited is the beneficiary of the encumbrance.
Disclosure made under SEBI (SAST) Regulations, 2011.

View BSE Filing

GUJTHEM

Pharmaceuticals

GUJARAT THEMIS BIOSYN LTD.

Price Impact